IXC looking to disrupt the ICP space. Proven science. Safe formulation. Some regulatory steps though path to market is pretty clear. Some risk in coming phase 3 though seems low. Phase 2 data strong to help prove efficacy. Vertical markets later in drugs life. Only real barrier to profit to my line of thought seems like time and patience…… with a sprinkling of opportunity cost.
IXC looking to disrupt the ICP space. Proven science. Safe...
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 158 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable